In an obese woman whose waist-to-hip ratio exceeds her hip ratio, which marker best indicates health risk: LDL, BMI, waist-to-hip ratio, or abdominal circumference?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Waist Circumference (D) Best Indicates Health Risk in This Obese Woman

For an obese woman with central adiposity (increased waist-to-hip ratio), waist circumference is the single best marker to indicate health risk among the options provided. 1, 2

Why Waist Circumference is Superior

The 2019 ACC/AHA guidelines explicitly state that waist circumference may be more useful than BMI in persons with abdominal obesity (central adiposity) 1. This directly addresses your clinical scenario. The guidelines emphasize that:

  • Central adiposity captured by waist circumference has been associated with ASCVD risk and may be missed when BMI is used as the only measure 1
  • Increased waist circumference has been directly associated with increased cardiometabolic and ASCVD risk 1
  • For women, waist circumference ≥35 inches (≥88 cm) indicates elevated cardiovascular risk 1, 2

Comparing the Options

Waist Circumference vs. Waist-Hip Ratio (WHR)

While WHR is mentioned in the question, waist circumference is simpler to measure and more clinically practical 1. The 2020 Endocrine Society guidelines note that waist circumference and WHR are both better measures of central obesity than BMI, but waist circumference measurement is relatively simple and recommended for routine clinical practice as "another vital sign" 2. Research shows waist circumference has stronger alignment with cardiometabolic outcomes 3.

Waist Circumference vs. BMI

BMI is recommended for primary screening of obesity 1, but the guidelines are clear that combining waist circumference and BMI is the best approach for assessing obesity-related risk 1. In your patient with central adiposity, BMI alone would miss the specific risk pattern. The 2020 consensus statement concluded that BMI and waist circumference identify high risk better than either measurement alone 2.

Waist Circumference vs. LDL

LDL is a cardiovascular risk factor but not a measure of adiposity or body fat distribution. It doesn't directly indicate the health risk from obesity itself.

Clinical Application

Waist circumference measurement is recommended in all patients with BMI <35 kg/m² 1. For this obese woman:

  • Measure at the midpoint between the lower rib margin and iliac crest 2
  • Risk threshold: ≥35 inches (88 cm) for women 1, 2
  • This measurement is needed for metabolic syndrome diagnosis 1
  • It predicts mortality better within each BMI category 2

Important Caveat

Waist circumference thresholds are not reliable for patients with BMI >35 4. In such cases, clinical judgment incorporating multiple measures becomes necessary.

The evidence consistently demonstrates that waist circumference is the most practical, validated, and clinically useful single marker for assessing health risk in patients with central obesity 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.